Apax Funds agree EUR 1.5 billion carve-out of Gerresheimer pharmaceutical packaging businesses

PUBT · 1d ago
Apax Funds agree EUR 1.5 billion carve-out of Gerresheimer pharmaceutical packaging businesses
  • Apax funds agreed to buy Gerresheimer’s Centor US Holding and its global Primary Packaging Plastics business in a carve-out valued at about EUR 1.5 billion.
  • The two units generated about EUR 570 million of revenue in 2025, operating 16 production sites across nine countries with about 2,400 employees.
  • Centor, which supplies prescription-drug dispensing packaging in the US, is expected to close by the end of fiscal 2026.
  • The Primary Packaging Plastics sale is expected to close in the first half of fiscal 2027.
  • Gerresheimer plans to use cash proceeds to cut leverage and lower interest expense alongside a broader refinancing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apax Partners Worldwide LLP published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.